Basic information Safety Related Supplier

ChemicalBook Product Catalog Amiprilose

1/1

Amiprilose NEW

$293.00 1mg

$722.00 5mg

$987.00 10mg

Min. Order
Purity99.82%
Cas No56824-20-5
Supply Ability10g
Update time2024-11-20

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

5YR

United States

show more

Chemical Properties

Product Name	Amiprilose
CAS No	56824-20-5
EC-No
Min. Order
Purity	99.82%
Supply Ability	10g
Release date	2024/11/20

Product Introduction

Bioactivity

Name	Amiprilose
Description	Amiprilose (SM 1213) has anti-inflammatory activity and inhibits the proliferation of a variety of hyperproliferative cell types.Amiprilose induces lymphokine-induced macrophage activation and may be used in studies of rheumatoid arthritis and psoriasis.
In vitro	Low concentrations of Amiprilose hydrochloride (1-100 μg/ml) stimulated proliferation of mouse thymocytes and enhanced IL-1-stimulated proliferative responses in human synovial fibroblasts.[1];In all three models, Amiprilose hydrochloride at concentrations of 0.1% (w/v) or less was not toxic to fibroblasts and keratinocytes and did not interfere with the differentiation of skin equivalents and developing skin equivalents. When tested in skin equivalents, Amiprilose hydrochloride concentrations between 0.1% and 0.5% resulted in altered fibroblast morphology with large intracellular vacuoles, and concentrations above 5% were toxic. In mature skin equivalents, Amiprilose hydrochloride at concentrations of 1% to 10% affected the epidermis in addition to changes in fibroblast morphology. During differentiation, epidermal keratinocytes are also affected when 0.5% Amiprilose hydrochloride is present in developing skin equivalents.[2]
In vivo	In 8 consecutive experiments, 90 Louvain (LOU) rats and 91 Sprague-Dawley (SD) rats were immunized with chick type II collagen and administered amiprilose HCl aqueous (1 mg/mL). In LOU rats, the incidence of arthritis was 7/46 (15%) in the amiprilose HCl group compared with 16/44 (36%) in the aqueous group (P less than 0.01). In SD rats, the incidence of arthritis was 28/46 (60%) in the experimental group and 33/45 (73%) in the control group (p greater than NS), but the incidence of arthritis was significantly lower in the experimental group on days 16 and 21 (p less than 0.03). In the LOU assay, amiprilose HCl did not affect antibody titers or delayed hypersensitivity to collagen, nor did it affect the distribution of T cell subsets. At a nontoxic concentration of 1 mg/mL, amiprilose HCl reduced 3H thymidine incorporation in cultured rabbit synovial fibroblasts by 78% and resulted in the presence of numerous intracytoplasmic granules/vacuoles. amiprilose HCl system also reduced prostaglandin E2 levels in rabbit synovial cell supernatant in a dose-related manner by as much as 73% without affecting collagenase activity. collagenase activity.[5]
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Keywords	Amiprilose
Inhibitors Related	Neomycin sulfate \| Dehydroacetic acid sodium \| Ampicillin sodium \| Methyl anthranilate \| Kanamycin sulfate \| Sulfamethoxazole sodium \| Metronidazole \| Doxycycline \| Dimethyl sulfoxide \| Crystal Violet
Related Compound Libraries	Bioactive Compound Library \| Anti-Aging Compound Library \| Bioactive Compounds Library Max

show more

Company Profile Introduction

You may like

Recommended supplier

MSDS|CAS|CAS DataBase|Pricacy|Terms|About Us|New Products| Contact us|Computer Version
Chemical Book